What is the role and impact of molecular markers on treatment decisions in the adjuvant setting ?

« What is the role and impact of molecular markers on treatment decisions in the adjuvant setting ? » : conférence de David Kerr (University of Oxford) le 8 décembre à 14h30 sur la Montagne Ste-Geneviève, dans le cadre des « Translational Research and Cancer seminars » organisés par La Fondation Pierre-Gilles de Gennes pour la Recherche, dont l’ESPCI ParisTech est membre.

This entry was posted on samedi, décembre 6th, 2008 at 9:00 and is filed under Non classé. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

Comments are closed.